转移性乳腺癌
医学
肿瘤科
乳腺癌
内科学
癌症
随机对照试验
作者
Binghe Xu,Shusen Wang,Min Yan,Joohyuk Sohn,Wei Li,Jin-hai Tang,Xiaojia Wang,Ying Wang,Seock‐Ah Im,Dongdong Jiang,T. Valdez,Anandaroop Dasgupta,Yiran Zhang,Yi‐Lin Yan,Kimberly M. Komatsubara,Wei‐Pang Chung,Fei Ma,Ming‐Shen Dai
标识
DOI:10.1038/s41591-024-03269-z
摘要
Sacituzumab govitecan (SG) significantly improved progression-free survival (PFS) and overall survival (OS) versus chemotherapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR
科研通智能强力驱动
Strongly Powered by AbleSci AI